Clinical Trials Directory

Trials / Completed

CompletedNCT04496232

Strategies for Reducing Sperm DNA Fragmentation in ICSI Semen Samples: a Prospective Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Ganin Fertility Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Comparing second ejaculate and physiological ICSI (PICSI) as strategies for improvement of abnormal sperm DNA fragmentation in patients undergoing ICSI.

Detailed description

Sperm DNA fragmentation has shown a negative correlation with embryo quality, fertilization, implantation, clinical pregnancy, and live birth rates. And a positive correlation with the miscarriage rate. Abnormal sperm DNA fragmentation can be improved through the second ejaculate strategy, by limiting the time of sperm presence in the epididymis. PICSI is a robust sperm selection technique that can select individual mature intact sperm DNA. In our study, we will compare PICSI as a valid sperm selection technique to second ejaculate, as a natural cost-free strategy to manage abnormal SDF. In addition to a normal SDF arm as a control.

Conditions

Interventions

TypeNameDescription
DEVICEPICSISemen processing by density gradient centrifugation followed by sperm selection by PICSI dishes of the first ejaculate
OTHERSecond ejaculateSemen processing by density gradient centrifugation for the second ejaculate

Timeline

Start date
2020-08-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2020-08-03
Last updated
2022-08-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04496232. Inclusion in this directory is not an endorsement.